Chemical activators of ZNF711 utilize a variety of intracellular pathways to promote the protein's activation through phosphorylation, a process where a phosphate group is added to the protein, altering its function. Phorbol 12-myristate 13-acetate (PMA) and 4α-Phorbol are known to activate protein kinase C (PKC), which targets serine and threonine residues on ZNF711 for phosphorylation, resulting in the protein's activation. This is a direct mechanism where PKC, upon activation by these chemicals, catalyzes the transfer of phosphate groups from ATP to ZNF711. Similarly, Forskolin, Dibutyryl-cAMP, and 8-Bromo-cAMP raise the levels of cyclic AMP (cAMP) within the cell, which in turn activates protein kinase A (PKA). PKA then phosphorylates ZNF711, thereby activating it. This cascade is a classic signaling pathway where the elevation of cAMP serves as a second messenger in the activation of PKA, which subsequently phosphorylates target proteins.
Additionally, Ionomycin and Thapsigargin lead to the rise of intracellular calcium levels, triggering the activation of calmodulin-dependent kinases. These kinases can also phosphorylate ZNF711, leading to its activation. Thapsigargin specifically inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) pump, causing calcium to accumulate within the cytosol and indirectly promoting the activation of kinases that target ZNF711. On another front, Okadaic Acid and Calyculin A inhibit protein phosphatases PP1 and PP2A, preventing the dephosphorylation of ZNF711, which keeps the protein in an active, phosphorylated state. Anisomycin is another chemical that takes a different route by activating the MAP kinase pathway, which includes ERK among other kinases. These kinases have the capability to phosphorylate ZNF711, leading to its functional activation. Lastly, while Chelerythrine and Bisindolylmaleimide I are typically inhibitors of PKC, they can lead to the activation of alternative kinases that can still phosphorylate ZNF711, highlighting the complex interplay within the cell where blocking one pathway can activate another, resulting in the desired phosphorylation and activation of ZNF711.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate serine and threonine residues on ZNF711, leading to its activation. PKC-mediated phosphorylation is known to regulate protein activity, and thus, PMA can induce activation of ZNF711 through this pathway. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA. The activation of PKA can lead to the phosphorylation and consequent activation of ZNF711, as PKA directly phosphorylates target proteins, enhancing their activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is another cAMP analog that activates PKA, which in turn can phosphorylate ZNF711, thereby leading to its activation. The chemical serves as a tool to mimic the effects of cAMP and activate downstream proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, activating calmodulin-dependent kinases which can phosphorylate ZNF711, thus leading to its activation. Elevated calcium levels are a known trigger for the activation of multiple cellular proteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA pump, leading to increased intracellular calcium levels, which activates kinases such as PKC that can phosphorylate ZNF711, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins. This inhibition could keep ZNF711 in a phosphorylated and active state by preventing dephosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A also inhibits protein phosphatases, such as PP1 and PP2A, which can maintain ZNF711 in a phosphorylated and active state, by hindering dephosphorylation processes. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the MAP kinase pathway, which includes kinases like ERK that can phosphorylate ZNF711 and activate it. The MAP kinase pathway is implicated in regulating the activities of various proteins. | ||||||
Phorbol | 17673-25-5 | sc-253267 | 5 mg | $270.00 | 1 | |
4α-Phorbol activates PKC, which subsequently phosphorylates serine and threonine residues on proteins such as ZNF711, leading to their activation. Phosphorylation by PKC is a well-documented mechanism for protein activation. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine, while typically a PKC inhibitor, can result in the activation of alternative kinases through compensatory cellular mechanisms which can phosphorylate and activate ZNF711. | ||||||